Alcohol and Substance Abuse in Solid-Organ Transplant Recipients

被引:49
|
作者
Parker, Richard [1 ,2 ,3 ]
Armstrong, Matthew J. [1 ,2 ,3 ]
Corbett, Chris [1 ,2 ,3 ]
Day, Edward J. [4 ]
Neuberger, James M. [3 ,5 ]
机构
[1] Univ Birmingham, Natl Inst Hlth Res Biomed Res Unit, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England
[3] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England
[4] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England
[5] NHS Blood & Transplant, Bristol, Avon, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
Alcohol; Drugs; Substance abuse; Transplantation; ORTHOTOPIC LIVER-TRANSPLANTATION; CARBOHYDRATE-DEFICIENT TRANSFERRIN; LONG-TERM GRAFT; ETHYL GLUCURONIDE; FOLLOW-UP; PSYCHOSOCIAL EVALUATION; INTERNATIONAL-SOCIETY; HEART-TRANSPLANTATION; LABORATORY MARKERS; SCREENING-TEST;
D O I
10.1097/TP.0b013e31829f7579
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review focuses on alcohol and substance abuse in the context of solid-organ transplantation. Alcohol and substance abuse are common and may lead to a need for solid-organ transplantation and may also contribute to significant physical and psychologic problems that impact upon the recipient. Damaging levels of alcohol intake can occur in the absence of dependence. Alcohol or substance abuse after transplantation is associated with poor medication compliance and this may increase risk of graft loss. Intravenous drug use is associated with increased risk of infections (especially secondary to opportunistic organisms-bacterial, viral, protozoal, and others-and such infections may be more severe in the immunosuppressed), but there is only anecdotal evidence that such behavior has a worse outcome in transplant recipients. Whereas previous alcohol excess and drug use in kidney recipients are both associated with a small but statistically significantly increased risk of adverse outcomes (hazard ratio, 1.16-1.56), alcohol use within recommended guidelines after transplantation appears safe and possibly beneficial. Robust data are lacking for other organs, but those available suggest that heart transplantation is safe in individuals with a history of alcohol or substance abuse. Health specialists in drug or alcohol addiction should carefully screen all potential transplant candidates for these conditions, and where there is evidence of dependency or abuse, effective psychologic and physical treatment should be offered. Studies have shown that interventions such as psychologic intervention have improved alcohol behavior in the context of liver transplantation. Although there are no comparable studies with other solid-organ recipients, it is reasonable to expect transferable outcomes.
引用
收藏
页码:1015 / 1024
页数:10
相关论文
共 50 条
  • [21] Parasitic Infections in Solid Organ Transplant Recipients
    Kotton, C. N.
    Lattes, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : S234 - S251
  • [22] Comparison of Serum and Bronchoalveolar Lavage Galactomannan in Diagnosing Invasive Aspergillosis in Solid-Organ Transplant Recipients
    Tabarsi, Payam
    Soraghi, Abdolreza
    Marjani, Majid
    Zandian, Paris
    Baghaei, Parvaneh
    Najafizadeh, Katayoon
    Droudinia, Atoosa
    Sarrafzadeh, Shokooh Azam
    Javanmard, Pedram
    Mansouri, Davood
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2012, 10 (03) : 278 - 281
  • [23] Pulmonary complications in patients receiving a solid-organ transplant
    De Gasperi, Andrea
    Feltracco, Paolo
    Ceravola, Elias
    Mazza, Ernestina
    CURRENT OPINION IN CRITICAL CARE, 2014, 20 (04) : 411 - 419
  • [24] Establishing a Solid-Organ Transplant Registry in MESOT Countries
    Masri, Marwan
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2024, 22 (01) : 1 - 13
  • [25] Hepatitis B in Solid-Organ Transplant Procedures Other Than Liver
    Halegoua-De Marzio, Dina
    Fenkel, Jonathan M.
    Doria, Cataldo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 (02) : 130 - 137
  • [26] Survival Benefit of Solid-Organ Transplant in the United States
    Rana, Abbas
    Gruessner, Angelika
    Agopian, Vatche G.
    Khalpey, Zain
    Riaz, Irbaz B.
    Kaplan, Bruce
    Halazun, Karim J.
    Busuttil, Ronald W.
    Gruessner, Rainer W. G.
    JAMA SURGERY, 2015, 150 (03) : 252 - 259
  • [27] Skin Cancer Risk Awareness and Sun-Protective Behavior Among Solid-Organ Transplant Recipients
    Vural, Ayse Tuncer
    Togral, Arzu Karatas
    Kirnap, Mahir
    Gulec, A. Tulin
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2018, 16 : 203 - 207
  • [28] Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis
    Jarrell, Andrew S.
    Crow, Jessica R.
    Strout, Sara E.
    Kruer, Rachel M.
    Toman, Lindsey P.
    Dioverti-Prono, Maria, V
    Lees, Laura
    Avery, Robin K.
    Marzinke, Mark A.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (01) : 101 - 106
  • [29] Chromoblastomycosis in Solid Organ Transplant Recipients
    Raaka Kumbhakar
    Benjamin A. Miko
    Current Fungal Infection Reports, 2019, 13 : 139 - 145
  • [30] Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients
    Alvarez-Lopez, Patricia
    Riveiro-Barciela, Mar
    Oleas-Vega, Diana
    Flores-Cortes, Claudia
    Roman, Antonio
    Perello, Manel
    Berastegui, Cristina
    Castells, Lluis
    Esteban, Rafael
    Buti, Maria
    MEDICINE, 2020, 99 (09)